Korean Chinese Japanese
  • Economy
  • Politics
  • Society
  • Securities
  • Real estate
  • Culture
  • Entertainment
  • Sports
  • Opinion
Korean Chinese Japanese
Economy Corporation Pharma & Bio
Society Politics IT·Science
Securities Real Estate Global
Opinion Entertainment Sports Culture
Video Auto in Golf in
PHARM EDAILY Market in TheBeLT
Pharma & Bio
Technology

Will 'Omliclo' and 'Zolear' Break the Duopoly and Expand the Market? Japanese Medical Professionals Are Also Taking Notice [WAC 2026]

Medical professionals are participating in a panel discussion at the Celltrion educational seminar held on the 16th at the Kyoto International Conference Center in Japan as part of the World Allergy C…
  • 2026-10-19 08:01:07
  • KIM SAE-MI
Technology

Hopes Rise for 'Omliclo' in Treating Pollen Allergy, a 'National Epidemic' in Japan… Will It Reduce the Burden of Drug Costs? [WAC 2026]

Kayoko Kawashima, Head of the Department of Otolaryngology at the Osaka Habikino Medical Center, delivered a lecture titled “Improving the Quality of Life for Patients with Severe Allergic Rhinitis” o…
  • 2026-10-19 08:01:06
  • KIM SAE-MI
Lifestyle

EyeGene,Inc to Build ‘Ailya Plant in the Snow’… to Begin Phase 1 and 2a Clinical Trials Next Year

“Instead of repeated injections of Eylea, we’re letting the eye produce it on its own.” EyeGene,Inc(185490)has presented a new paradigm for the treatment of age-related macular degeneration.The key is…
  • 2026-10-19 08:01:05
  • KIM JI-WAN
Technology

[Expert Insight] “We Must Not Stop at Simply Lowering the Numbers”… The Challenge Lies in Improving Fatty Liver with Soy Sauce-Based Solutions

“We need stronger clinical evidence that goes beyond a simple reduction in liver enzyme levels to demonstrate actual structural and pathological improvements in the liver.”Kim Seung-eop, a professor i…
  • 2026-10-19 07:42:03
  • NA EUN-KYUNG
Lifestyle

"Higher Cell Recovery Rate at 1/200th the Concentration of Salmon"… "Rose PDRN Strikes Back"

“Showed a higher cell recovery rate at 1/200th the concentration of salmon-derived PDRN.”BIO-FD&C Co.,Ltd.(251120)has entered the salmon-based skin improvement ingredients market with PDRN derived fro…
  • 2026-10-19 07:21:02
  • KIM JI-WAN
Technology

LigaChem Bio Looks Beyond Late Entry, Targets Drug-Resistant Cancer Market Amid Biotech Rebound [K-Bio Pulse]

On Oct. 16, South Korean pharmaceutical and biotech stocks rallied, buoyed by overnight gains in U.S. healthcare shares and a broader rebound in domestic equities. Samsung Epis Holdings and Samyang Bi…
  • 2026-10-19 07:06:02
  • Minji Son
Technology

LigaChem Biosciences’ Bold Move Amid the Biotech Rebound… Moving Beyond “Latecomer” Status to Target the Resistant Market [Biotech Spotlight]

Overnight, pharmaceutical and biotech stocks performed strongly on the New York Stock Exchange, bringing a tailwind to domestic pharmaceutical and biotech stocks on the 16th. On the Korea Composite St…
  • 2026-10-19 07:02:02
  • Minji Son
Technology

Obesity Drug with 49 Trillion Won in Sales—Now Available as a Patch?…Domestic Companies Take Note of Lilly’s Research

It has been confirmed that Eli Lilly is researching microneedle patch technology applicable to tirzepatide and retatruotide. Research into patch applications for its flagship weight-loss drug and foll…
  • 2026-10-19 06:01:03
  • NA EUN-KYUNG
Technology

Preclinical Stage but Worth $400 Million… Merck’s Choice of Chinese Anticancer Drug Comes with Different Terms Than Those of K-Bio

(Graphic: ChatGPT) Merck (MSD) has bet $400 million in upfront payments alone on a preclinical anti-cancer candidate from Chinese biotech firm SciBrunch Therapeutics. The company has agreed to pay…
  • 2026-10-18 08:01:03
  • Minji Son
Technology

Black Thursday: DuChemBio, Yuhan, and Curiox Emerge as Rare Bright Spots [K-BIO Pulse]

South Korea’s pharmaceutical and biotechnology sectors took a heavy hit on October 15, with the vast majority of stocks ending the session in negative territory. Of the 161 stocks in the pharmaceutica…
  • 2026-10-17 07:21:03
  • KIM JI-WAN
prev 11 12 13 14 15 16 17 18 19 20 next

PHARM EDAILY

Shorts

EDAILY
  • 92, Tongil-ro, Jung-gu, Seoul, Korea
  • +82 2 3772 0114
  • webmaster@edaily.co.kr

※ This article has been translated using AI technology for the convenience of readers.

EDAILY provides this translation on an “as is” basis and makes no warranties, express or implied, regarding its accuracy, reliability, completeness, merchantability, or fitness for a particular purpose.
Due to the limitations of machine translation, the translated content may differ from the original Korean article. In the event of any discrepancy, the original Korean version shall prevail.
EDAILY shall not be liable for any loss or damage arising from the use of, or reliance on, the translated content.

© 2026 Copyrights by edaily. All Rights Reserved.
Korea China Japan
English